Amedeo Smart

Free Medical Literature Service

 

Amedeo

Kidney Transplantation
  Free Subscription

Articles published in
J Am Soc Nephrol
    April 2024
  1. VAULET T, Callemeyn J, Lamarthee B, Antoranz A, et al
    The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.
    J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000350.
    >> Share

  2. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    >> Share

    March 2024
  3. CHANDRAKER A, Regmi A, Gohh R, Sharma A, et al
    Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    J Am Soc Nephrol. 2024 Mar 12. doi: 10.1681/ASN.0000000000000329.
    >> Share

  4. LAN JH
    Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape.
    J Am Soc Nephrol. 2024;35:259-260.
    >> Share

    January 2024
  5. ADLER JT, Kuk AE, Cron DC, Parast L, et al
    Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
    J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
    >> Share

  6. BAE S, McAdams-DeMarco MA
    Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:130.
    >> Share

  7. LI Y, Luo F, Gao Q, Su L, et al
    Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:129.
    >> Share

    December 2023
  8. VINCENTI F, Bestard O, Brar A, Cruzado JM, et al
    Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
    J Am Soc Nephrol. 2023 Dec 26. doi: 10.1681/ASN.0000000000000287.
    >> Share

  9. HUSAIN SA
    Recentering Accountability for Disparities in Kidney Transplant Access.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
    >> Share

  10. RAYNAUD M, Al-Awadhi S, Louis K, Zhang H, et al
    Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal.
    J Am Soc Nephrol. 2023 Dec 6. doi: 10.1681/ASN.0000000000000260.
    >> Share

  11. RIZZOLO K, Cervantes L, Wilhalme H, Vasilyev A, et al
    Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure.
    J Am Soc Nephrol. 2023;34:2013-2023.
    >> Share

    October 2023
  12. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
    Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
    J Am Soc Nephrol. 2023;34:1615-1617.
    >> Share

  13. GREGORY AV, Denic A, Moustafa A, Dasaraju PG, et al
    The Number and Size of Individual Kidney Medullary Pyramids is Associated with Clinical Characteristics, Kidney Biopsy Findings, and CKD Outcomes among Kidney Donors.
    J Am Soc Nephrol. 2023;34:1752-1763.
    >> Share

    August 2023
  14. YU M, King KL, Husain SA, Huml AM, et al
    Discrepant Outcomes between National Kidney Transplant Data Registries in the United States.
    J Am Soc Nephrol. 2023 Aug 3. doi: 10.1681/ASN.0000000000000194.
    >> Share

    July 2023
  15. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
    Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
    J Am Soc Nephrol. 2023 Jul 25. doi: 10.1681/ASN.0000000000000209.
    >> Share

  16. GOLSHAYAN D, Schwotzer N, Fakhouri F, Zuber J, et al
    Targeting the Complement Pathway in Kidney Transplantation.
    J Am Soc Nephrol. 2023 Jul 13. doi: 10.1681/ASN.0000000000000192.
    >> Share

    May 2023
  17. HIRT-MINKOWSKI P, Handschin J, Stampf S, Hopfer H, et al
    Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine.
    J Am Soc Nephrol. 2023 May 25. doi: 10.1681/ASN.0000000000000160.
    >> Share

  18. ZHU J, Xiang X, Hu X, Li C, et al
    miR-147 Represses NDUFA4, Inducing Mitochondrial Dysfunction and Tubular Damage in Cold-storage Kidney Transplantation.
    J Am Soc Nephrol. 2023 May 22. doi: 10.1681/ASN.0000000000000154.
    >> Share

  19. BELAND S, Desy O, El Fekih R, Marcoux M, et al
    Expression of Class II Human Leukocyte Antigens on Human Endothelial Cells Shows High Interindividual and Intersubclass Heterogeneity.
    J Am Soc Nephrol. 2023;34:846-856.
    >> Share

    March 2023
  20. GRIFFIN MD, Malone AF
    Endothelial Expression of Class II MHC Proteins: A New Layer of Complexity in Kidney Transplantation.
    J Am Soc Nephrol. 2023 Mar 24. doi: 10.1681/ASN.0000000000000115.
    >> Share

  21. BAEKMD S, AhnKMD JB, Joseph C, Whisler R, et al
    Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.
    J Am Soc Nephrol. 2023 Mar 9. doi: 10.1681/ASN.0000000000000112.
    >> Share

    February 2023
  22. REISCHIG T, Vlas T, Kacer M, Pivovarcikova K, et al
    A Randomized Trial of Valganciclovir Prophylaxis versus Preemptive Therapy in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2023 Feb 2. doi: 10.1681/ASN.0000000000000090.
    >> Share

  23. MORGAN JC, Foster BJ, Vinson AJ, Wong G, et al
    Navigating the Dobbs versus Jackson America for Patients with CKD and Kidney Transplants.
    J Am Soc Nephrol. 2023;34:201-204.
    >> Share

  24. SAWINSKI D, Hendren E, Cunningham A, Niederhaus SV, et al
    The Importance of Maintaining Reproductive Choices for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2023;34:198-200.
    >> Share

    January 2023
  25. GRIFFIN MD, Perico N, Casiraghi F
    Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action.
    J Am Soc Nephrol. 2023;34:4-7.
    >> Share

  26. PUTTARAJAPPA CM, Hariharan S, Zhang X, Tevar A, et al
    Early Effect of the Circular Model of Kidney Allocation in the United States.
    J Am Soc Nephrol. 2023;34:ASN.
    >> Share

    December 2022
  27. ROSALES IA, Mahowald GK, Tomaszewski K, Hotta K, et al
    Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection.
    J Am Soc Nephrol. 2022;33:2306-2319.
    >> Share

    November 2022
  28. DENIC A, Bogojevic M, Subramani R, Park WD, et al
    Changes in Glomerular Volume, Sclerosis, and Ischemia at 5 Years after Kidney Transplantation: Incidence and Correlation with Late Graft Failure.
    J Am Soc Nephrol. 2022 Nov 17. pii: ASN.2022040418. doi: 10.1681/ASN.2022040418.
    >> Share

  29. VAULET T, Divard G, Thaunat O, Koshy P, et al
    Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies.
    J Am Soc Nephrol. 2022;33:2026-2039.
    >> Share

    October 2022
  30. DOAN NGOC TM, Tilly G, Danger R, Bonizec O, et al
    Effector Memory-Expressing CD45RA (TEMRA) CD8(+) T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses.
    J Am Soc Nephrol. 2022 Oct 24. pii: ASN.2022030286. doi: 10.1681/ASN.2022030286.
    >> Share

  31. SHARIF A
    Targeting the Right Metrics for Kidney Transplantation Success.
    J Am Soc Nephrol. 2022 Oct 12. pii: ASN.2022080872. doi: 10.1681/ASN.2022080872.
    >> Share

  32. HRICIK D, Armstrong B, Alhamad T, Brennan D, et al
    Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients.
    J Am Soc Nephrol. 2022 Oct 4. pii: ASN.2022040454. doi: 10.1681/ASN.2022040454.
    >> Share

    September 2022
  33. BISSONNETTE MLZ, Riazy M, Cunningham AM, Gill JS, et al
    A Step toward Understanding the Story Behind the Pictures: Molecular Diagnostics and the Banff Classification of Renal Allograft Pathology.
    J Am Soc Nephrol. 2022 Sep 28. pii: ASN.2022070847. doi: 10.1681/ASN.2022070847.
    >> Share

  34. MORATH C, Schaier M, Ibrahim E, Wang L, et al
    Induction of Long-lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2022 Sep 22. pii: ASN.2022020210. doi: 10.1681/ASN.2022020210.
    >> Share

    August 2022
  35. SUN Z, Zhang Z, Banu K, Azzi YA, et al
    Blood Transcriptomes of SARS-CoV-2-Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity.
    J Am Soc Nephrol. 2022 Aug 30. pii: ASN.2022010125. doi: 10.1681/ASN.2022010125.
    >> Share

  36. DANGI A, Husain I, Jordan CZ, Yu S, et al
    Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function.
    J Am Soc Nephrol. 2022 Aug 16. pii: ASN.2022020139. doi: 10.1681/ASN.2022020139.
    >> Share

  37. WANG K, Deng Y, Stewart D, Formica RN Jr, et al
    A Composite End Point of Graft Status and eGFR at 1 Year to Improve the Scientific Registry of Transplant Recipients' Five-Tier Rating System.
    J Am Soc Nephrol. 2022;33:1613-1624.
    >> Share

    July 2022
  38. LASTER M, Norris KC
    Equitable Transplantation: A Modifiable Risk Factor for Disparities in Mortality in ESKD.
    J Am Soc Nephrol. 2022;33:1240-1241.
    >> Share

  39. BECERRA AZ, Chan KE, Eggers PW, Norton J, et al
    Transplantation Mediates Much of the Racial Disparity in Survival from Childhood-Onset Kidney Failure.
    J Am Soc Nephrol. 2022;33:1265-1275.
    >> Share

    June 2022
  40. KNOLL G, Campbell P, Chasse M, Fergusson D, et al
    Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort Study.
    J Am Soc Nephrol. 2022;33:1182-1192.
    >> Share

    March 2022
  41. VINSON A, Singh S, Chadban S, Cherney D, et al
    Premature Death in Kidney Transplant Recipients: The Time for Trials is Now.
    J Am Soc Nephrol. 2022 Mar 15. pii: ASN.2021111517. doi: 10.1681/ASN.2021111517.
    >> Share

    February 2022
  42. WIJTVLIET V, Wissing KM, Abramowicz D, Ledeganck KJ, et al
    SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
    J Am Soc Nephrol. 2022 Feb 14. pii: ASN.2021121566. doi: 10.1681/ASN.2021121566.
    >> Share

  43. SCHREZENMEIER E, Sattler A, Halleck F, Budde K, et al
    Authors' Reply: SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
    J Am Soc Nephrol. 2022 Feb 14. pii: ASN.2022010033. doi: 10.1681/ASN.2022010033.
    >> Share

  44. DU LONG R, Florquin S, Kers J
    Advanced Tertiary Lymphoid Tissues in Protocol Biopsies in Kidney Transplant Recipients: Addressing Additional Methods To Detect Intragraft B Cells.
    J Am Soc Nephrol. 2022 Feb 3. pii: ASN.2021111509. doi: 10.1681/ASN.2021111509.
    >> Share

  45. SATO Y, Lee YH, Taniguchi K, Yoshikawa T, et al
    Authors' Reply: Advanced Tertiary Lymphoid Tissues in Protocol Biopsies in Kidney Transplant Recipients: Addressing Additional Methods To Detect Intragraft B Cells.
    J Am Soc Nephrol. 2022 Feb 3. pii: ASN.2021121588. doi: 10.1681/ASN.2021121588.
    >> Share

  46. KORFIATIS P, Denic A, Edwards ME, Gregory AV, et al
    Automated Segmentation of Kidney Cortex and Medulla in CT Images: A Multisite Evaluation Study.
    J Am Soc Nephrol. 2022;33:420-430.
    >> Share

    January 2022
  47. HALLORAN PF, Reeve J, Madill-Thomsen KS, Demko Z, et al
    The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    J Am Soc Nephrol. 2022 Jan 20. pii: ASN.2021091191. doi: 10.1681/ASN.2021091191.
    >> Share

  48. JORGENSEN H, Behets G, Bammens B, Claes K, et al
    Natural History of Bone Disease Following Kidney Transplantation.
    J Am Soc Nephrol. 2022 Jan 19. pii: ASN.2021081081. doi: 10.1681/ASN.2021081081.
    >> Share

  49. FILA M, Debiec H, Perrochia H, Djouadi N, et al
    Recurrence of Anti-semaphorin-3B Mediated Membranous Nephropathy after Kidney Transplantation.
    J Am Soc Nephrol. 2022 Jan 11. pii: ASN.2021101323. doi: 10.1681/ASN.2021101323.
    >> Share

    December 2021
  50. LAMARTHEE B, Burger C, Leclaire C, Lebraud E, et al
    CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021;32:3231-3251.
    >> Share

  51. CHANDRAN S, Stock PG
    COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.
    J Am Soc Nephrol. 2021;32:2977-2978.
    >> Share

    November 2021
  52. KAMINSKI H, Marseres G, Yared N, Nokin MJ, et al
    mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional alphabeta and gammadelta T cells in Kidney Transplantation.
    J Am Soc Nephrol. 2021 Nov 1. pii: ASN.2020121753. doi: 10.1681/ASN.2020121753.
    >> Share

  53. LEE YH, Sato Y, Saito M, Fukuma S, et al
    Advanced Tertiary Lymphoid Tissues in Protocol Biopsies are Associated with Progressive Graft Dysfunction in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021 Nov 1. pii: ASN.2021050715. doi: 10.1681/ASN.2021050715.
    >> Share

  54. GUPTA A, Kaplan B
    Need for a Validation Study before Using the Two-Step Algorithm for dd-cfDNA to Screen for Acute Rejection.
    J Am Soc Nephrol. 2021;32:2972-2973.
    >> Share

  55. GILL JS, Schold J, Kaplan B
    Understanding Risks and Our Responsibility to Living Donors.
    J Am Soc Nephrol. 2021;32:2691-2693.
    >> Share

  56. IBRAHIM HN, Murad DN, Hebert SA, Adrogue HE, et al
    Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.
    J Am Soc Nephrol. 2021;32:2933-2947.
    >> Share

    October 2021
  57. BUDDE K, Prashar R, Haller H, Rial M, et al
    Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.
    J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050628. doi: 10.1681/ASN.2021050628.
    >> Share

  58. SCHREZENMEIER E, Rincon-Arevalo H, Stefanski AL, Potekhin A, et al
    B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021 Oct 19. pii: ASN.2021070966. doi: 10.1681/ASN.2021070966.
    >> Share

  59. ALTHAGE M, Heinrich TM, Miliotis T, Bogstedt A, et al
    Urine APOL1 Isoforms Reflect Plasma-Derived Liver-Synthesized Proteins.
    J Am Soc Nephrol. 2021;32:2442-2444.
    >> Share

    September 2021
  60. WETMORE J, Johansen K, Liu J, Peng Y, et al
    Changes in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2021 Sep 17. pii: ASN.2021040579. doi: 10.1681/ASN.2021040579.
    >> Share

    August 2021
  61. MATAS AJ, Mannon RB, Rush D, Helgeson E, et al
    Novel Phenotypes for Acute Kidney Transplant Rejection Using Semi-supervised Clustering.
    J Am Soc Nephrol. 2021 Aug 16. pii: ASN.2021040572. doi: 10.1681/ASN.2021040572.
    >> Share

  62. SCHWAIGER E, Krenn S, Kurnikowski A, Bergfeld L, et al
    Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial.
    J Am Soc Nephrol. 2021;32:2083-2098.
    >> Share

  63. SHARIF A
    Prevention of Post-Transplantation Diabetes: Small Steps, Big Opportunities.
    J Am Soc Nephrol. 2021;32:1833-1834.
    >> Share

  64. CALLEMEYN J, Senev A, Coemans M, Lerut E, et al
    Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
    J Am Soc Nephrol. 2021;32:2070-2082.
    >> Share

  65. WEWERS TM, Schulz A, Nolte I, Pavenstadt H, et al
    Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia.
    J Am Soc Nephrol. 2021;32:1853-1863.
    >> Share

    July 2021
  66. MADILL-THOMSEN K, Boehmig G, Bromberg J, Einecke G, et al
    Donor-Specific Antibody is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified As No Rejection.
    J Am Soc Nephrol. 2021 Jul 12. pii: ASN.2021040433. doi: 10.1681/ASN.2021040433.
    >> Share

    June 2021
  67. SCHOLD JD, Huml AM, Poggio ED, Sedor JR, et al
    Patients with High Priority for Kidney Transplant Who Are Not Given Expedited Placement on the Transplant Waiting List Represent Lost Opportunities.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2020081146. doi: 10.1681/ASN.2020081146.
    >> Share

  68. DANTHU C, Hantz S, Dahlem A, Duval M, et al
    Humoral Response after SARS-Cov-2 mRNA Vaccine in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021 Jun 16. pii: ASN.2021040490. doi: 10.1681/ASN.2021040490.
    >> Share

  69. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    J Am Soc Nephrol. 2021 Jun 10. pii: ASN.2021040480. doi: 10.1681/ASN.2021040480.
    >> Share

  70. BUSCHER K, Heitplatz B, Van Marck V, Song J, et al
    Data Driven Kidney Transplant Phenotyping as a Histology-independent Framework for Biomarker Discovery.
    J Am Soc Nephrol. 2021 Jun 2. pii: ASN.2020121685. doi: 10.1681/ASN.2020121685.
    >> Share


  71. Addendum: Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act-a Chance to Celebrate and Reflect.
    J Am Soc Nephrol. 2021;32:1540.
    >> Share

  72. WEINHANDL ED, Wetmore JB, Peng Y, Liu J, et al
    Initial Effects of COVID-19 on Patients with ESKD.
    J Am Soc Nephrol. 2021;32:1444-1453.
    >> Share

  73. MAYRDORFER M, Liefeldt L, Wu K, Rudolph B, et al
    Exploring the Complexity of Death-Censored Kidney Allograft Failure.
    J Am Soc Nephrol. 2021;32:1513-1526.
    >> Share

    May 2021
  74. LENTINE K, Kasiske B, Axelrod D
    When More Information May Not Lead to Better Decisions: Defining the Role of Procurement Biopsies in Kidney Transplantation.
    J Am Soc Nephrol. 2021 May 27. pii: ASN.2021030403. doi: 10.1681/ASN.2021030403.
    >> Share

  75. STEINER RW
    How Many Disparate Measurements of Kidney Function Unfairly Allow Selected Candidates to Accumulate Time on the Deceased Donor Kidney Transplant Waiting List?
    J Am Soc Nephrol. 2021 May 21. pii: ASN.2021030415. doi: 10.1681/ASN.2021030415.
    >> Share

    April 2021
  76. VASQUEZ-RIOS G, Menon MC
    Kidney Transplant Rejection Clusters and Graft Outcomes: Revisiting Banff in the Era of "Big Data".
    J Am Soc Nephrol. 2021 Apr 6. pii: ASN.2021030348. doi: 10.1681/ASN.2021030348.
    >> Share

    March 2021
  77. SCHMIDT IM, Waikar SS
    Separate and Unequal: Race-Based Algorithms and Implications for Nephrology.
    J Am Soc Nephrol. 2021;32:529-533.
    >> Share

    February 2021
  78. HARUHARA K, Sasaki T, de Zoysa N, Okabayashi Y, et al
    Podometrics in Japanese Living Donor Kidneys: Associations with Nephron Number, Age, and Hypertension.
    J Am Soc Nephrol. 2021 Feb 24. pii: ASN.2020101486. doi: 10.1681/ASN.2020101486.
    >> Share

  79. REESE PP, Aubert O, Naesens M, Huang E, et al
    Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes.
    J Am Soc Nephrol. 2021;32:397-409.
    >> Share

  80. AHLENSTIEL-GRUNOW T, Liu X, Schild R, Oh J, et al
    Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial.
    J Am Soc Nephrol. 2021;32:502-516.
    >> Share

    January 2021
  81. DREXLER Y, Molina J, Mitrofanova A, Fornoni A, et al
    Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
    J Am Soc Nephrol. 2021;32:9-31.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016